Anna L. Blobaum

Also affiliated with Center for Discovery

NeuroscienceBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Discovery of VU0467319: an M1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials”.

Discovery of VU0467319: an M1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials

ACS Chemical Neuroscience(2024)10.1021/acschemneuro.4c00769

N/A

0.457DataRank · unranked

11 citations

Michael R. Wood, Changho Han, Shaun R. Stauffer, Joseph D. Panarese, Bruce J. Melancon +21 more

Development and profiling of mGlu7 NAMs with a range of saturable inhibition of agonist responses in vitro

Bioorganic & Medicinal Chemistry Letters(2022)10.1016/j.bmcl.2022.128923

N/A

0.208DataRank · unranked

3 citations

Alice L. Rodriguez, Jacob J. Kalbfleisch, Mabel Seto, Matthew T. Jenkins, Anna L. Blobaum +4 more

Discovery and Optimization of a Novel Series of Competitive and Central Nervous System-Penetrant Protease-Activated Receptor 4 (PAR4) Inhibitors

ACS Chemical Neuroscience(2021)10.1021/acschemneuro.1c00557

N/A

0DataRank · unranked

4 citations

Matthew T. Duvernay, Sidnee G. Mitchell, Shannon T. Smith, Jae G. Maeng, Anna L. Blobaum +5 more

Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c00192

N/A

0DataRank · unranked

23 citations

Douglas L. Orsi, Rory A. Capstick, David Whomble, Jinming Li, Trever R. Carter +21 more

Discovery of VU6007496: Challenges in the Development of an M1 Positive Allosteric Modulator Backup Candidate

ACS Chemical Neuroscience(2024)10.1021/acschemneuro.4c00508

N/A

0DataRank · unranked

8 citations

Katrina A. Bollinger, Rory A. Capstick, Madeline F. Long, Aaron M. Bender, Jonathan W. Dickerson +14 more

Modulation of arousal and sleep/wake architecture by M1 PAM VU0453595 across young and aged rodents and nonhuman primates

Neuropsychopharmacology(2020)10.1038/s41386-020-00812-7

N/A

0DataRank · unranked

20 citations

Jason K Russell, Michael T. Nedelcovych, Michael Bubser, Anna L. Blobaum, Thomas M. Bridges +6 more

Discovery of Thieno[3,2-b]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5

ACS Medicinal Chemistry Letters(2025)10.1021/acsmedchemlett.5c00119

N/A

0DataRank · unranked

2 citations

Scott H. Henderson, Rory A. Capstick, David Whomble, Aaron M. Bender, Andrew S. Felts +18 more

Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors

Bioorganic & Medicinal Chemistry Letters(2020)10.1016/j.bmcl.2020.127418

N/A

0DataRank · unranked

8 citations

Sean R. Bollinger, Andrew S. Felts, Anish K. Vadukoot, Charles H. Williams, Anna L. Blobaum +4 more